Related Experiment Video

Updated: Nov 9, 2025

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

478

Successful treatment of Brunsting-Perry pemphigoid with dupilumab

Franklin R Blum1, Justin R Sigmon2

  • 1University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina.

JAAD Case Reports
|April 14, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BPP, Brunsting-Perry pemphigoidBrunsting-Perry pemphigoidFDA, Food and Drug AdministrationIL-13, interleukin 13IL-4, interleukin 4cicatricial pemphigoiddupilumab

More Related Videos

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

609
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

353

Related Experiment Videos

Last Updated: Nov 9, 2025

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

478
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

609
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

353

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

216
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
216

Articles linked to this work by shared authors, journal, and citation graph.

Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.

The British journal of dermatology·2025

Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens.

The Journal of investigative dermatology·2024

Genetic Variants Associated With Hidradenitis Suppurativa.

JAMA dermatology·2023

Concomitance of Hidradenitis Suppurativa and Porokeratoses.

The Journal of clinical and aesthetic dermatology·2023

Anifrolumab for treatment of refractory cutaneous lupus erythematosus.

Clinical and experimental dermatology·2022

Cutaneous Pseudoepitheliomatous Hyperplasia from a Displaced Metallic Orthopedic Implant.

Case reports in dermatological medicine·2022

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us